Understanding Dry Eye Disease

[Author: Paul S. Jensen, O.D. ] In the last decade, tremendous advances have been made in understanding dry eye disease.  Landmark collaborations such as the Dry Eye Workshop and their reports have changed practice guidelines and improved patient care.  One type of dry eye might require more attention, though.  Among the … [Read more...]

Clinical Utility of Objective Tests for Dry Eye Disease: Variability Over Time and Implications for Clinical Trials and Disease Management.

tearlab test for dry eye disease

In a recent pre-publication release in the "Cornea" journal, tear osmolarity showed both treatment response and evidence of lower variability compared with other commonly used signs of Dry Eye Disease (DED).  The study included DED patients being treated over a 3 month period utilizing topical cyclosporine 0.05% (Restasis).  By … [Read more...]

Don’t ignore the Ocular Surface in your Premium IOL Patients

Summary: In Ocular Surgery News, Mitch Jackson, MD reports that " managing patient expectations, conducting the preoperative evaluation and addressing cystoid macular edema are all critical aspects in making the premium IOL patient happy and ensuring a premium outcome. However, ignoring the ocular surface, one of the remaining … [Read more...]

Dry Eye Clinics Add Value to Your Practice

A dry eye clinic can be a very important part of a comprehensive ophthalmology practice.   By Sheldon Herzig, MD, FRCSC   Dry eye syndrome (DES) has increasingly become a major concern, particularly as eye care specialists face growing numbers of cases arising from iatrogenic causes like PRK and LASIK. It has … [Read more...]

Using TearLab for Dry Eye Detection in Refractive Surgery Patients

In a poster presented at the winter ESCRS, the TearLab Osmolarity Test and Schirmer's test were compared to see which is a more accurate predictor of post-refractive surgery dry eye disease when performed in pre-operative refractive surgery patients. Results showed that by the end of postoperative month 1, pre-LASIK … [Read more...]

Breakthrough in Diagnosing Dry Eye and Staging Disease Severity

In January's edition of Cataract and Refractive Surgery Today,  Jay Pepose, MD, PhD says.... A lot depends on treating patients with dry eye disease. Nearly one in five individuals in North America has dry eye disease (DED); it may be one of the most common yet frequently undiagnosed and untreated problems seen every day by … [Read more...]

TearLab Osmolarity System CLIA Waiver Issued By FDA

SAN DIEGO, January 24, 2012 -- TearLab Corporation (NASDAQ:TEAR; TSX:TLB) ("TearLab" or the "Company") announced today that, after reviewing and accepting labeling submitted to it by the Company, the U.S Food and Drug Administration (“FDA”) has now granted Waiver categorization under the Clinical Laboratory Improvement … [Read more...]

ESTABLISHING A DRY EYE SUBSPECIALTY CLINIC

reviewlogo_2012

See this weeks Practice Pearl from Paul Karpecki, OD where he discusses the many diagnostic instruments he would like to include in his "dream dry eye practice". He mentions the TearLab Osmolarity System, among others. http://www.revoptom.com/email/010912_pearl86_v2.html … [Read more...]

TearLab Achieves Equal Reimbursement Across All States

December has turned out to be quite a month for TearLab Corporation. TearLab achieved their largest milestone last week when they received FDA communication granting them the CLIA waiver for the TearLab® Osmolarity System (pending labeling agreements). In addition, in a press release on Tuesday of this week, TearLab announced … [Read more...]

TearLab continues to gain acceptance amongst thought leaders

logo

TearLab’s (NASDAQ:TEAR; TSX:TLB) osmolarity test for dry eye disease continues to make impressive inroads in gaining awareness and acceptance among U.S. eye doctors. TearLab Osmolarity Test For example, an article entitled “Tear Osmolarity in the Diagnosis and Management of Dry Eye Disease,” which appeared in the … [Read more...]